The main objective of this study was to explain the metformin as a marvelous drug beyond diabetes. In earlier days, metformin was used to cure diabetes but in recent days metformin shows different pharmacological actions (as an anticancer, as an antiviral, as an antimalarial, in polycystic ovarian syndrome, in non alcoholic fatty liver disease, as an antiaging, as an anti-inflammatory, in auto immunity, in renal replacement therapy, in hypothyroidism etc.) in living cells. Due to these different many effects of metformin, this biguanide is known as “Sanjivani for human healthâ€.
Choose the style your journal or department asks for, then copy it.
Every version below is generated from this paper's own record.
IJRTI — journal style
"METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.6, Issue 9, page no.18 - 20, September-2021, Available :https://ijrti.org/papers/IJRTI2109005.pdf
APA — 7th edition
Shukla, P. (2021). METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES. International Journal for Research Trends and Innovation, 6(9), 18 - 20. https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
MLA — 9th edition
Shukla, Pranki. "METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES." International Journal for Research Trends and Innovation, vol. 6, no. 9, 2021, pp. 18 - 20, https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005.
Chicago — 17th, bibliography
Shukla, Pranki. "METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES." International Journal for Research Trends and Innovation 6, no. 9 (2021): 18 - 20. https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005.
Harvard — author–date
Shukla, P. (2021) 'METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES', International Journal for Research Trends and Innovation, 6(9), pp. 18 - 20. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
IEEE — numbered reference
P. Shukla, "METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES," IJRTI, vol. 6, no. 9, pp. 18 - 20, Sep. 2021.
Vancouver — biomedical
Shukla P. METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES. IJRTI. 2021 Sep;6(9):18 - 20.
AMA — 11th edition
Shukla P. METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES. IJRTI. 2021;6(9):18 - 20. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2109005,
author = {Pranki Shukla},
title = {METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES},
journal = {International Journal for Research Trends and Innovation},
volume = {6},
number = {9},
pages = {18 - 20},
year = {2021},
month = {September},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Shukla, Pranki
TI - METFORMIN MAY PROVE TO BE A MARVELOUS DRUG FARTHER DIABETES
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 6
IS - 9
PY - 2021
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2109005
SP - 18
EP - 20
ER -
International Journal for Research Trends and InnovationPublished by IJRTI (JW Publication)
2456-3315ISSN
10.57Impact Factor
2016ESTD Year
OpenAccess
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.